Management of Acute Bacterial Meningitis in Children

Area of Science:

• Pediatrics
• Infectious Diseases
• Neurology

Background:

• Acute community-acquired bacterial meningitis (ABM) in children presents significant neurological morbidity and mortality risks.
• Despite declining infection rates due to vaccines and prophylaxis, ABM remains a critical pediatric concern.
• Distinguishing bacterial from viral meningitis is challenging, particularly with prior antibiotic exposure.

Purpose of the Study:

• To review the epidemiology of pediatric ABM.
• To discuss diagnostic approaches including imaging, clinical models, and biomarkers.
• To cover management strategies, adjunctive therapies, and prevention methods for ABM.

Main Methods:

• Literature review on pediatric acute community-acquired bacterial meningitis.
• Analysis of diagnostic tools: cranial imaging, clinical models, inflammatory biomarkers.
• Evaluation of advanced diagnostic techniques like multiplex PCR and metagenomic sequencing.
• Review of current management and prevention strategies.

Main Results:

• Prompt diagnosis and early antibiotic therapy are critical for improving outcomes in pediatric ABM.
• Clinical models and biomarkers show promise in aiding the diagnosis of bacterial meningitis.
• Multiplex PCR and metagenomic next-generation sequencing offer potential for early and accurate diagnosis.
• Effective management includes timely antibiotics, potential adjunctive therapies, and preventive measures.

Conclusions:

• Acute bacterial meningitis in children necessitates rapid diagnosis and treatment to mitigate severe neurological sequelae.
• Advanced diagnostic tools and biomarkers are crucial for differentiating bacterial from viral meningitis.
• A comprehensive approach encompassing epidemiology, diagnosis, management, and prevention is essential for combating pediatric ABM.